Results 171 to 180 of about 678,448 (346)

Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

Journal of Hepatology, 2020
C. Rose, P. Amodio, J. Bajaj, R. Dhiman, S. Montagnese, S. Taylor-Robinson, H. Vilstrup, R. Jalan   +7 more
semanticscholar   +1 more source

Microbiome Therapeutics for Hepatic Encephalopathy.

Journal of Hepatology, 2021
P. Bloom, E. Tapper, V. Young, A. Lok
semanticscholar   +1 more source

Model Based Framework for Estimating Mutation Rate of Hepatitis C Virus in Egypt [PDF]

arXiv, 2013
Hepatitis C virus (HCV) is a widely spread disease all over the world. HCV has very high mutation rate that makes it resistant to antibodies. Modeling HCV to identify the virus mutation process is essential to its detection and predicting its evolution.
arxiv  

CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Venous thromboembolism (VTE) is a recognized complication of acutely ill patients, but its incidence and risk factors in those with cirrhosis are uncertain. Methods We retrospectively studied a consecutive cohort of cirrhosis patients non‐electively admitted to our medical unit to determine the rates of symptomatic VTE during
Alberto Zanetto, Alessandro Vitale, Filippo Pelizzaro, Vittorio Simeon, Elena Campello, Laura Turco, Lorenz Balcar, Francesco Paolo Russo, Patrizia Burra, Paolo Simioni, Marco Senzolo   +10 more
wiley   +1 more source

Influence of Intracellular Delay on the Dynamics of Hepatitis C Virus [PDF]

arXiv, 2014
In this paper we present a delay induced model for hepatitis C virus incorporating the healthy and infected hepatocytes as well as infectious and noninfectious virions. The model is mathematically analyzed and characterized, both for the steady states and the dynamical behavior of the model.
arxiv  

Rifaximin‐α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Hepatic encephalopathy is a frequent complication of cirrhosis. Rifaximin‐α has been included in guidelines for secondary prevention of hepatic encephalopathy, but there are few real‐world data on its efficacy and impact on healthcare utilization.
Diederick J. van Doorn, Kirsi. M. A. van Eekhout, Koos de Wit, L. C. Baak, Michael Klemt‐Kropp, Bart J. Verwer, Philip Friederich, Gijs J. de Bruin, Xander G. Vos, Joost P. H. Drenth, R. Bart Takkenberg   +10 more
wiley   +1 more source

The neurogliovascular unit in hepatic encephalopathy

JHEP Reports, 2021
Wouter Claeys, Lien Van Hoecke, S. Lefere, A. Geerts, X. Verhelst, H. Van Vlierberghe, H. Degroote, L. Devisscher, R. Vandenbroucke, C. Van Steenkiste   +9 more
semanticscholar   +1 more source

Minimum hepatic encephalopathy

Saudi Journal of Gastroenterology, 2010
Sir, I read the article ‘Predictors of minimal hepatic encephalopathy in patients with cirrhosis’ by Sharma et al. with interest.[1] The authors have conducted an interesting study, but a few points need to be highlighted. Studies done in the past have also shown the correlation between EEG (electroencephalography) and psychometric hepatic ...
openaire   +3 more sources

Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening Method

United European Gastroenterology Journal, EarlyView.
ABSTRACT Backround Minimal hepatic encephalopathy is a common and prognostically severe complication of cirrhosis with a significant impact on the quality of life. Detailed diagnostic work‐up of minimal hepatic encephalopathy is time‐consuming and difficult to integrate into daily clinical routine.
Henrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, Johanna Beder, Sven Danneberg, Katharina Mitzlaff, Iris Engelbart, Jakob Jessberger, Felix Braun, Thomas Becker, Christian Labenz, Monique Janneck, Denys Matthies, Friedhelm Sayk, Jens U. Marquardt   +14 more
wiley   +1 more source

Diagnosis and Monitoring Pathways Using Non‐Invasive Tests in Patients With Alpha‐1 Antitrypsin Deficiency‐Associated Liver Disease: Results From an Expert Delphi Panel

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims The severe alpha‐1 antitrypsin deficiency (AATD) genotype Pi*ZZ increases the risk of liver disease (AATD‐LD) and lung disease. While non‐invasive tests (NITs) are widely used for fibrosis stage and monitoring of all liver diseases, the consensus for use in AATD‐LD is limited.
Virginia C. Clark, Mark A. Price, Jon Russo, Rohit Loomba, Alice M. Turner, Pavel Strnad   +5 more
wiley   +1 more source